Cyteir Therapeutics, Inc. (CYT) 是一家上市公司 属于 医疗保健 板块，经营于 生物科技 行业. 公司总部位于 Lexington, MA, 美国. 现任CEO为 Markus F. Renschler.
CYT 拥有 IPO日期为 2021-06-18, 46 名全职员工, 在 NASDAQ Global Select, 市值为 $108.71M.
Cyteir Therapeutics, Inc., a clinical-stage biotechnology company, develops and commercializes the next-generation of precision oncology medicines. Its lead product CYT-0851, a novel, oral, once-daily, small molecule drug candidate that is in Phase I/II clinical trial for monotherapy in solid tumors and hematologic malignancies, as well as for combination therapy in solid tumors and hematologic malignancies. The company is also developing CYT-1853, which is in preclinical trials for solid tumors and hematologic malignancies. The company was incorporated in 2012 and is based in Lexington, Massachusetts.
